[Skip to Navigation]
News From the Food and Drug Administration
September 15, 2020

CBD Drug Is Approved for a Third Form of Epilepsy

JAMA. 2020;324(11):1026. doi:10.1001/jama.2020.16782

A drug containing the marijuana derivative cannabidiol (CBD) was approved to treat seizures associated with tuberous sclerosis complex (TSC) in patients aged 1 year or older. TSC is a genetic disease that causes benign tumors to grow throughout the body. It affects 1 in 6000 people.

×